Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment (Q74221067)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475563%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475563%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Drotar DE

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475563%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Davis EE

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475563%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Cockcroft DW

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475563%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475563%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475563%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475563%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475563%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

31-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475563%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Long- versus short-acting beta 2-agonists. Implications for drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Rapid Onset of Tolerance to the Bronchoprotective Effect of Salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Bronchial reactivity to inhaled histamine: a method and clinical survey

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Regular inhaled salbutamol and airway responsiveness to allergen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Regular use of inhaled albuterol and the allergen-induced late asthmatic response

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Functional antagonism: tolerance produced by inhaled beta 2 agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Airway responsiveness to histamine as a test for overall severity of asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Tolerance to the protective effect of salmeterol on allergen challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962935-3

7 January 2021

10.1016/S1081-1206(10)62935-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475563%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference